$VSEE
VSEE HEALTH, INC.

2024 Q3 Form 10-Q Financial Statement

#000155837024015753 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $3.354M $0.00
YoY Change
Cost Of Revenue $941.4K $478.4K
YoY Change 96.78%
Gross Profit $2.413M $973.1K
YoY Change 147.98%
Gross Profit Margin 71.94%
Selling, General & Admin $518.1K
YoY Change -54.13%
% of Gross Profit 53.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.253K $191.00
YoY Change 3697.38%
% of Gross Profit 0.3% 0.02%
Operating Expenses $59.48M $518.1K
YoY Change 11380.69% -54.13%
Operating Profit -$57.07M -$518.1K
YoY Change 10914.84% -54.13%
Interest Expense $596.4K
YoY Change 52.28%
% of Operating Profit
Other Income/Expense, Net $4.765M $596.4K
YoY Change 698.92% 52.28%
Pretax Income -$52.30M $78.29K
YoY Change -66907.46% -110.61%
Income Tax -$550.0K -$233.7K
% Of Pretax Income -298.54%
Net Earnings -$51.75M $78.29K
YoY Change -66204.88% -109.54%
Net Earnings / Revenue -1542.78%
Basic Earnings Per Share -$3.43 $0.02
Diluted Earnings Per Share -$3.43 $0.02
COMMON SHARES
Basic Shares Outstanding 15.08M 4.183M
Diluted Shares Outstanding 15.08M 4.183M

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $510.00
YoY Change -98.87%
Cash & Equivalents $2.327M $507.00
Short-Term Investments
Other Short-Term Assets $17.50K
YoY Change -71.01%
Inventory
Prepaid Expenses $17.50K
Receivables $2.613M
Other Receivables $560.4K
Total Short-Term Assets $7.108M $18.01K
YoY Change 39370.83% -82.91%
LONG-TERM ASSETS
Property, Plant & Equipment $794.7K
YoY Change
Goodwill $4.917M
YoY Change
Intangibles $11.55M
YoY Change
Long-Term Investments $8.120M
YoY Change -93.07%
Other Assets
YoY Change
Total Long-Term Assets $17.92M $8.120M
YoY Change 120.73% -93.07%
TOTAL ASSETS
Total Short-Term Assets $7.108M $18.01K
Total Long-Term Assets $17.92M $8.120M
Total Assets $25.03M $8.138M
YoY Change 207.58% -93.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.630M
YoY Change 84.88%
Accrued Expenses $31.65K
YoY Change
Deferred Revenue $683.1K
YoY Change
Short-Term Debt $1.940M
YoY Change 4320.16%
Long-Term Debt Due $439.2K
YoY Change
Total Short-Term Liabilities $19.21M $5.022M
YoY Change 282.44% 224.1%
LONG-TERM LIABILITIES
Long-Term Debt $593.9K $0.00
YoY Change
Other Long-Term Liabilities $4.370M
YoY Change 0.0%
Total Long-Term Liabilities $593.9K $4.370M
YoY Change -86.41% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.21M $5.022M
Total Long-Term Liabilities $593.9K $4.370M
Total Liabilities $20.27M $9.392M
YoY Change 115.83% 58.66%
SHAREHOLDERS EQUITY
Retained Earnings -$61.52M -$9.772M
YoY Change 529.63% 74.9%
Common Stock $1.536K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.149M
YoY Change
Total Liabilities & Shareholders Equity $25.03M $8.138M
YoY Change 207.58% -93.06%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$51.75M $78.29K
YoY Change -66204.88% -109.54%
Depreciation, Depletion And Amortization $7.253K $191.00
YoY Change 3697.38%
Cash From Operating Activities -$50.58K
YoY Change -65.39%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$410.00
YoY Change
Cash From Investing Activities -$410.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.50K
YoY Change
NET CHANGE
Cash From Operating Activities -50.58K
Cash From Investing Activities -410.0
Cash From Financing Activities 14.50K
Net Change In Cash -36.49K
YoY Change -75.03%
FREE CASH FLOW
Cash From Operating Activities -$50.58K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration
FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001864531
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 vsee Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2023Q3 vsee Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2024Q3 vsee Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2024Q3 vsee Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2023Q3 vsee Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2023Q3 vsee Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2024Q3 vsee Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2024Q3 vsee Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q3 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration
FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y
CY2024Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#FinanceLeaseLiabilityCurrent
CY2024Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#FinanceLeaseLiabilityNoncurrent
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y
vsee Future Receipts Sale Agreement Period Over Which Amount Is To Be Collected By Purchaser Weekly
FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly
P0Y
CY2024Q3 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration
FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://vseehealth.com/20240930#FairValueAdjustmentOfFinancialInstruments
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41015
dei Entity Registrant Name
EntityRegistrantName
VSee Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2970927
dei Entity Address Address Line1
EntityAddressAddressLine1
980 N Federal Hwy
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 304
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33432
dei City Area Code
CityAreaCode
516
dei Local Phone Number
LocalPhoneNumber
672-7068
dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
DIGITAL HEALTH ACQUISITION CORP.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2327337
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118734
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2062444
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32457
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2613327
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
628480
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
560380
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1606469
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
79920
CY2024Q3 us-gaap Assets Current
AssetsCurrent
7107513
CY2023Q4 us-gaap Assets Current
AssetsCurrent
827134
CY2024Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
245500
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
417835
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11547500
CY2024Q3 us-gaap Goodwill
Goodwill
4916694
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
794688
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3657
CY2024Q3 us-gaap Assets
Assets
25029730
CY2023Q4 us-gaap Assets
Assets
830791
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8270393
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1824408
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
683111
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
802524
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
456858
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
338506
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
68958
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
191330
CY2024Q3 vsee Factoring Payable Current
FactoringPayableCurrent
208788
CY2024Q3 vsee Business Combination Purchase Consideration Payable Current
BusinessCombinationPurchaseConsiderationPayableCurrent
265978
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
63855
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
135000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
600000
CY2024Q3 us-gaap Senior Notes Current
SeniorNotesCurrent
495000
CY2024Q3 vsee Notes Payable Current Net Of Discount
NotesPayableCurrentNetOfDiscount
439183
CY2023Q4 vsee Notes Payable Current Net Of Discount
NotesPayableCurrentNetOfDiscount
220000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
19206202
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4243438
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
593941
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
289263
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
181312
CY2024Q3 us-gaap Liabilities
Liabilities
20270718
CY2023Q4 us-gaap Liabilities
Liabilities
4243438
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6158
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6158
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
1
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15362278
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15362278
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4639643
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4639643
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1536
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
464
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66282056
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6027153
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61524581
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9114985
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-325279
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4759012
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3412647
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25029730
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
830791
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3354437
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1451471
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6561998
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4337962
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
941388
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
478399
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1814281
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1528008
CY2024Q3 us-gaap Gross Profit
GrossProfit
2413049
CY2023Q3 us-gaap Gross Profit
GrossProfit
973072
us-gaap Gross Profit
GrossProfit
4747717
us-gaap Gross Profit
GrossProfit
2809954
CY2024Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1678627
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1013488
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3490615
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3433658
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2170217
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
224874
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2830615
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
832513
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54984000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54984000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
646303
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9066
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1653448
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
66411
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
59479147
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1247428
us-gaap Operating Expenses
OperatingExpenses
62958678
us-gaap Operating Expenses
OperatingExpenses
4332582
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-57066098
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-274356
us-gaap Operating Income Loss
OperatingIncomeLoss
-58210961
us-gaap Operating Income Loss
OperatingIncomeLoss
-1522628
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
232082
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
36312
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
591087
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
163574
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19619
CY2024Q3 vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
-5737606
CY2023Q3 vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
21629
vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
-6285706
vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
-92448
vsee Gian Loss On Issuance Of Financial Instruments
GianLossOnIssuanceOfFinancialInstruments
-1618234
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-740979
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-740979
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4764543
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-57941
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3335406
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-51507
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52301555
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-332297
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54875555
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1574135
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-550030
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-233716
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2791238
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-590954
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-51751525
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-98581
us-gaap Profit Loss
ProfitLoss
-52084317
us-gaap Profit Loss
ProfitLoss
-983181
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12465
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3727
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-51751525
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-111046
us-gaap Net Income Loss
NetIncomeLoss
-52084317
us-gaap Net Income Loss
NetIncomeLoss
-986908
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.43
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.43
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15077548
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15077548
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9998446
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9998446
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8351249
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8351249
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9998446
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9998446
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3412647
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2811
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
31980
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3383478
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-31980
CY2024Q2 vsee Stock Issued During Period Value Escrow Shares Released From Stock Payable
StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable
127710
CY2024Q2 vsee Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
-17381444
CY2024Q2 vsee Preferred Stock Issued During Period Value Settlement Of Debt As Part Of Consideration In Acquisition
PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition
220000
CY2024Q2 vsee Preferred Stock Issued During Period Value Settlement Of Underwriting Fee As Part Of Consideration In Acquisition
PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition
4370000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31989
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-329981
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
54810556
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
625750
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
349095
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-51751525
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4759012
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2033
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-451252
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4767
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-458052
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-424610
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3971
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-886633
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-111046
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12465
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-985214
us-gaap Profit Loss
ProfitLoss
-52084317
us-gaap Profit Loss
ProfitLoss
-983181
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54984000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-740979
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
98000
vsee Gian Loss On Issuance Of Financial Instruments
GianLossOnIssuanceOfFinancialInstruments
-1618234
vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
-6285706
vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
-92448
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
93000
vsee Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
17209
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
381084
us-gaap Depreciation And Amortization
DepreciationAndAmortization
651761
us-gaap Depreciation And Amortization
DepreciationAndAmortization
395
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
342634
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
95815
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2336506
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-590952
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
203904
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
286602
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-225654
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
861888
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-57168
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-161975
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
988798
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-76823
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-119413
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
13561
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
63855
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-210797
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
181010
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2815248
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-523436
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
29123
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50507
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2690
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21384
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2690
vsee Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
1323362
vsee Repayment On Factoring Payable
RepaymentOnFactoringPayable
150616
vsee Payment For Consideration Liability Financing Activities
PaymentForConsiderationLiabilityFinancingActivities
3090
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
47800
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
363982
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
120000
vsee Proceeds From Share Repurchase Liability
ProceedsFromShareRepurchaseLiability
135000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5045235
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
455000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2208603
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71126
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118734
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230664
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2327337
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159538
us-gaap Interest Paid Net
InterestPaidNet
6738
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3092
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
18704806
vsee Stock Issued To Sponsor For Debt Settlement
StockIssuedToSponsorForDebtSettlement
1268000
vsee Stock Issued To Underwriter
StockIssuedToUnderwriter
4370000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1310710
vsee Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Fair Value Of Shares Issued
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFairValueOfSharesIssued
68907052
vsee Stock Issued For Debt Settlement In Acquisition
StockIssuedForDebtSettlementInAcquisition
325279
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14692820
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Company’s condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the condensed consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, the determination of estimated provision for contractual adjustments from third-party payors in the recognition of patient fee contracts, goodwill impairment analysis, allowance for credit losses, the fair value of the ELOC, the Exchange Note, the Additional Bridge Note (as defined below in the “<i style="font-style:italic;">Additional Bridge Financing</i>” section), and the Quantum Convertible Note, the September 2024 Convertible Note, and income taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. However, future events are subject to change and best estimates and judgments routinely require adjustment. Actual results could differ from those estimates.</p>
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
646303
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9066
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1653448
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
66411
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-51751525
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-111046
us-gaap Net Income Loss
NetIncomeLoss
-52084317
us-gaap Net Income Loss
NetIncomeLoss
-986908
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15077548
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15077548
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9998446
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9998446
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8351249
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8351249
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9998446
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9998446
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.43
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.43
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.00
CY2024Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.00
CY2024Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
2.00
CY2024Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
2.00
CY2024Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.00
CY2024Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.00
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2024Q2 vsee Accounts Receivable Allowance For Credit Loss Increase From Acquisition
AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition
1696553
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2062444
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32457
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
321206
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
73097
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
342634
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
95815
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32457
vsee Accounts Receivable Allowance For Credit Loss Increase From Acquisition
AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition
1696553
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
342634
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
32457
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
9200
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2062444
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32457
vsee Fixed Asset Recognition Threshold
FixedAssetRecognitionThreshold
1000
us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54984000
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54984000
CY2024Q2 us-gaap Goodwill
Goodwill
59900694
CY2024Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
54984000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12100000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
552500
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11547500
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
552500
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
552500
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2210000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2210000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2210000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2210000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2155000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11547500
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54984000
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54984000
CY2024Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
3354437
CY2023Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
3076235
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
9191682
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
9390435
CY2024Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-368063
CY2023Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1322199
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-2436877
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-3435940
CY2024Q3 vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic
15077548
CY2024Q3 vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Diluted
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted
15077548
CY2023Q3 vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic
14806820
CY2023Q3 vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Diluted
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted
14806820
vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic
14821999
vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Diluted
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted
14821999
vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic
14602506
vsee Business Acquisition Pro Forma Weighted Average Shares Outstanding Diluted
BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted
14602506
CY2024Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.09
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.16
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.16
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.24
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.24
CY2024Q3 vsee Business Acquisition Pro Forma Amortization Of Intangible Assets
BusinessAcquisitionProFormaAmortizationOfIntangibleAssets
-552500
CY2023Q3 vsee Business Acquisition Pro Forma Amortization Of Intangible Assets
BusinessAcquisitionProFormaAmortizationOfIntangibleAssets
-552500
vsee Business Acquisition Pro Forma Amortization Of Intangible Assets
BusinessAcquisitionProFormaAmortizationOfIntangibleAssets
-1657500
vsee Business Acquisition Pro Forma Amortization Of Intangible Assets
BusinessAcquisitionProFormaAmortizationOfIntangibleAssets
-1657500
CY2023Q3 vsee Business Acquisition Pro Forma Transaction Expenses
BusinessAcquisitionProFormaTransactionExpenses
67316
vsee Business Acquisition Pro Forma Transaction Expenses
BusinessAcquisitionProFormaTransactionExpenses
301013
vsee Business Acquisition Pro Forma Transaction Expenses
BusinessAcquisitionProFormaTransactionExpenses
335430
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2024Q2 vsee Estimated Value Of Shares And Options Granted
EstimatedValueOfSharesAndOptionsGranted
60500000
CY2024Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
292500
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14692820
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
894627
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4335
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
99939
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
678
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
794688
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3657
CY2024Q3 us-gaap Depreciation
Depreciation
7253
CY2023Q3 us-gaap Depreciation
Depreciation
191
us-gaap Depreciation
Depreciation
9735
us-gaap Depreciation
Depreciation
395
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
85986
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
89526
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0
CY2024Q3 vsee Operating Lease Liabilities Included In Accounts Payable And Accrued Liabilities
OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities
87710
CY2023Q4 vsee Operating Lease Liabilities Included In Accounts Payable And Accrued Liabilities
OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities
0
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
31890
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
128520
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
131440
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
125400
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
82880
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
500130
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
141909
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
358221
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
13476
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
13476
us-gaap Operating Lease Cost
OperatingLeaseCost
17209
us-gaap Operating Lease Expense
OperatingLeaseExpense
17209
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.179
CY2024Q3 vsee Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
3
vsee Lessee Finance Lease Monthly Payments
LesseeFinanceLeaseMonthlyPayments
20313
CY2024Q3 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.193
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
736624
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
89526
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
647098
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
372642
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
191330
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
181312
CY2024Q3 vsee Financing Lease Liabilities Included In Accounts Payable And Accrued Liabilities
FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities
385951
CY2023Q4 vsee Financing Lease Liabilities Included In Accounts Payable And Accrued Liabilities
FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities
0
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
85986
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
19175
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
89526
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
19734
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
63733
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
243758
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
136484
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
443975
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
71333
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
372642
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.193
vsee Future Receipts Sale Agreement Interest Rate
FutureReceiptsSaleAgreementInterestRate
0
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1939783
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
220000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
439183
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
220000
CY2024Q3 vsee Long Term Debt Fair Value Adjustments
LongTermDebtFairValueAdjustments
906659
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
593941
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
439183
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4567
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
26534
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
37720
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
39008
CY2024Q3 vsee Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1392771
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1939783
CY2023Q4 vsee Debt Instrument Convertible Maximum Reset Of Conversion Price
DebtInstrumentConvertibleMaximumResetOfConversionPrice
2.00
CY2023Q4 vsee Deferred Underwriting Fee
DeferredUnderwritingFee
4370000
CY2023Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
135000
CY2023Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
135000
CY2024Q2 vsee Gain Loss On Debt Conversion
GainLossOnDebtConversion
20565
us-gaap Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
0
CY2024Q3 us-gaap Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
0
CY2024Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
1049985
CY2024Q3 vsee Purchase Commitment Adjustments And Payments Made
PurchaseCommitmentAdjustmentsAndPaymentsMade
967308
CY2023Q4 vsee Purchase Commitment Adjustments And Payments Made
PurchaseCommitmentAdjustmentsAndPaymentsMade
639752
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
82677
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
410233
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3459310
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2463599
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-550030
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2791238
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-233716
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-590954
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.375
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
vsee Threshold Ownership Percentage Eligible To Vote
ThresholdOwnershipPercentageEligibleToVote
0.0499
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 vsee Conversion Of Stock Equivalent Common Stock Shares Upon Conversion
ConversionOfStockEquivalentCommonStockSharesUponConversion
12165889
CY2024Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
4879067
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.40
CY2024Q2 vsee Shares To Be Issued At Inception And Later For Consulting Services Per Agreement
SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement
25000
CY2024Q2 vsee Shares To Be Issued At Inception And Later For Consulting Services Per Agreement
SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement
25000
CY2024Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
31250
CY2024Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2500
CY2024Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
25000
CY2024Q3 vsee Shares Issued For Services Of Placement Agent Shares
SharesIssuedForServicesOfPlacementAgentShares
25000
CY2024Q3 vsee Shares Issued For Prior Services Of Placement Agent Shares
SharesIssuedForPriorServicesOfPlacementAgentShares
66750
CY2024Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200000
CY2024Q3 vsee Fair Value Of Shares Of Common Stock
FairValueOfSharesOfCommonStock
534000
CY2024Q3 vsee Loss On Conversion Of Accounts Payable To Equity
LossOnConversionOfAccountsPayableToEquity
534000
CY2024Q3 vsee Stock Issued During Period Shares Debt Issuance
StockIssuedDuringPeriodSharesDebtIssuance
100000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15362278
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4639643
vsee Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
803646
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M23D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
629344
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y8M23D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.00
CY2024Q2 us-gaap Share Price
SharePrice
12.11
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
12.11
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0500
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0446
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1013138
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5034045
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
349095
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
381084
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
vsee Class Of Warrant Or Right Assumed
ClassOfWarrantOrRightAssumed
12256999
vsee Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
740741
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12997740
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12997740
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9.65
vsee Warrants And Rights Outstanding Weighted Average Remaining Term
WarrantsAndRightsOutstandingWeightedAverageRemainingTerm
P4Y2M19D
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6561998
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4337962
us-gaap Operating Income Loss
OperatingIncomeLoss
-58210961
us-gaap Operating Income Loss
OperatingIncomeLoss
-1522628
us-gaap Operating Income Loss
OperatingIncomeLoss
-58210961
us-gaap Operating Income Loss
OperatingIncomeLoss
-1522628
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
591087
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
163574
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
19619
vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
-6285706
vsee Fair Value Adjustment Of Financial Instruments
FairValueAdjustmentOfFinancialInstruments
-92448
vsee Gian Loss On Issuance Of Financial Instruments
GianLossOnIssuanceOfFinancialInstruments
-1618234
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-740979
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3335406
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-51507
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54875555
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1574135
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2791238
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-590954
us-gaap Profit Loss
ProfitLoss
-52084317
us-gaap Profit Loss
ProfitLoss
-983181
CY2024Q3 us-gaap Assets
Assets
25029730
CY2023Q4 us-gaap Assets
Assets
830791
CY2024Q3 us-gaap Goodwill
Goodwill
4916694
us-gaap Depreciation And Amortization
DepreciationAndAmortization
651761
us-gaap Depreciation And Amortization
DepreciationAndAmortization
395
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
50507
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2690
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
591087
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
163574
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7350083
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
33000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
13889
vsee Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Into Equity
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoEquity
608157
vsee Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Extensions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExtensions
5000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-6273271
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7630000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-015753-index-headers.html Edgar Link pending
0001558370-24-015753-index.html Edgar Link pending
0001558370-24-015753.txt Edgar Link pending
0001558370-24-015753-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vsee-20240930.xsd Edgar Link pending
vsee-20240930x10q.htm Edgar Link pending
vsee-20240930xex31d1.htm Edgar Link pending
vsee-20240930xex31d2.htm Edgar Link pending
vsee-20240930xex32d1.htm Edgar Link pending
vsee-20240930_cal.xml Edgar Link unprocessable
vsee-20240930_def.xml Edgar Link unprocessable
vsee-20240930_lab.xml Edgar Link unprocessable
vsee-20240930_pre.xml Edgar Link unprocessable
vsee-20240930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable